ArticleSkin health and disease2021

Cutaneous sarcoidosis due to immune-checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor.

J P Pham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.